Eli Lilly: Co, Hims & Hers Health Announced Agreement To Help Expand Access To Zepbound (Tirzepatide) & Foundayo (Orforglipron)

Agreement Gives Patients Path To FDA-Approved Treatments At Self-Pay Price Through The Hims & Hers Platform Self-Pay Pricing Starts At $149 Per Month For Foundayo & $299 Per Month For Zepbound Hims & Hers Has Committed Not To Offer Access To Compounded Copies Of Lilly s GLP-1s In Future